Attachment 2 Type of institution: national laboratory (Government-owned, contractor-operated) and uranium processing center and associated research facilities Mission: processing and associated biomedical research; general research; and cancer research Links: DOD/Armed Forces Special Weapons Project; NASA; PHS; associated universities; contractor operators; radioisotope licensees; extramural contractors and grantees Experiments or other radiation research: * Manhattan Project fuel processing began in 1942; radioisotope distribution began in 1947; research institute began operating cancer research hospital in 1950 Secret or classified research: Yes, but extent and nature unknown * types of experiments: plutonium injection (1945); total body irradiation (1950-1970's); cancer therapy with short-lived radionuclides (1950 - ?); supported extramural contractor performing uranium experiments (1950's); supported prisoner experiments (date unknown); regulated extramural radioisotope use through licensing process (1946 - ?); environmental releases (late 1940's); experiments of opportunity in industrial accidents. * number of experiments: unknown AVAILABLE DATA Experiments: * Histories of research program: partially collected, others should be readily obtainable * "Start/stop" documents for specific experiments/programs: partially collected, others should be readily obtainable * Publications or reports for specific experiments/programs : partially collected, others should be readily obtainable Program: * Record of chains of command for program decisions and review : partially collected, others should be readily obtainable; DOD records on AFSWP presence not yet explored * Funding source: AEC with NASA funding of TBI; DOD funding suspected but not yet determined; records requested but not yet produced 1 Was there secret or classified funding? Yes, but extent, source and purpose not yet explored Consent: What was the extant consent policy? AEC consent memorandum required informed consent in the presence of a witness; cancer hospital used patient admissions brochure and written release * The institutional form for the policy: Multiple oversight, including AEC isotope licensing committee; human use committee at cancer hospital after 1966 * Records of implementation: Waiver/release form, brochure; Isotope Division records not located Subject selection: Patients at cancer hospital selected based on research suitability; otherwise not yet known OVERSIGHT Multiple committees: ORINS Advisory, Advisory Committee on Biology and Medicine, Human Use subcommittee for isotope licensing; actual practical oversight not yet established 2